The histopathology of non-steroidal anti-inflammatory drug induced gastroduodenal damage:: correlation with Helicobacter pylori, ulcers, and haemorrhagic events

被引:19
|
作者
Frezza, M
Gorji, N
Melato, M
机构
[1] Gen Hosp, Gastroenterol Unit, I-34149 Trieste, Italy
[2] Univ Trieste, I-34127 Trieste, Italy
[3] Gen Hosp, Dept Anat Pathol, Trieste, Italy
关键词
chemical gastritis; non-steroidal anti-inflammatory drugs; Helicobacter pylori;
D O I
10.1136/jcp.54.7.521
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Aims-The spectrum of microscopic lesions resulting from the chronic use of non-steroidal anti-inflammatory drugs (NSAIDs), known as chemical gastritis, remains unclear, and the variable prevalence reported in different studies makes this issue a matter of lively debate. The aim of this study was to evaluate the prevalence and importance of chemical gastritis in patients regularly taking NSAIDs. Owing to the high prevalence of Helicobacter pylori infection, particularly in subjects over 60 years of age, and in view of a possible association with damage, the presence of H pylori infection in the same tissue sample was also determined in all patients. Methods-One hundred and ninety seven subjects were enrolled, 118 off whom were receiving chronic treatment with NSAIDs and 79 of whom were controls, pair matched for age, sex, and clinical symptoms (ulcer-like dyspepsia or upper digestive tract haemorrhage). Antral biopsies taken during upper gastroduodenal endoscopy were assessed for chemical gastritis according to a modified version of Dixon's score, and for helicobacter correlated chronic active gastritis, according to the updated Sydney system. Results-Chemical gastritis was identified in 11 patients taking NSAIDs (9%) and in four controls (5%) (p < 0.05). Helicobacter pylori was detected in 53 patients taking NSAIDs (45%) and in 34 controls (43%). Patients taking NSAIDs had a significantly higher number of erosions and ulcers and worse endoscores than controls. The presence of H pylori did not appear to increase histological damage, ulcer prevalence, or haemorrhagic events. Conclusions-Chemical gastritis is present in a limited number of patients regularly taking NSAIDs, and is not strongly correlated with NSAID induced damage. In many cases of peptic ulcer or upper gastrointestinal bleeding in patients taking NSAIDs, the presence of chemical gastritis or H pylori infection cannot solely account for the development of mucosal damage.
引用
收藏
页码:521 / 525
页数:5
相关论文
共 50 条
  • [31] Helicobacter pylori management in non-steroidal anti-inflammatory drug therapy patients in primary care
    Angelo Zullo
    Cesare Hassan
    Diodato Oliveti
    Alberto Chiriatti
    Diana Anna Elisa Chiuri
    Gemma Marotti
    Lara Morelli
    Sergio Morini
    Internal and Emergency Medicine, 2012, 7 : 331 - 335
  • [32] Helicobacter pylori management in non-steroidal anti-inflammatory drug therapy patients in primary care
    Zullo, Angelo
    Hassan, Cesare
    Oliveti, Diodato
    Chiriatti, Alberto
    Chiuri, Diana Anna Elisa
    Marotti, Gemma
    Morelli, Lara
    Morini, Sergio
    INTERNAL AND EMERGENCY MEDICINE, 2012, 7 (04) : 331 - 335
  • [33] Pathogenesis of gastroduodenal lesions induced by non-steroidal anti-inflammatory drugs
    Lamarque, D
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2004, 28 : C18 - C26
  • [34] PREVENTION OF GASTRODUODENAL DAMAGE INDUCED BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS - CONTROLLED TRIAL OF RANITIDINE
    EHSANULLAH, RSB
    PAGE, MC
    TILDESLEY, G
    WOOD, JR
    BRITISH MEDICAL JOURNAL, 1988, 297 (6655): : 1017 - 1021
  • [35] Non-steroidal anti-inflammatory drugs, Helicobacter pylori and bleeding gastric ulcer
    Ng, TM
    Fock, KM
    Khor, JL
    Teo, EK
    Sim, CS
    Tan, AL
    Machin, D
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2000, 14 (02) : 203 - 209
  • [36] Helicobacter pylori infection increases the risk of peptic ulcers in chronic users of non-steroidal anti-inflammatory drugs
    Li, EKM
    Sung, JJY
    Suen, R
    Ling, TKW
    Leung, VKS
    Hui, E
    Cheng, AFB
    Chung, S
    Woo, J
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1996, 25 (01) : 42 - 46
  • [37] Primary gastroduodenal prophylaxis with omeprazole for non-steroidal anti-inflammatory drug users
    Cullen, D
    Bardhan, KD
    Eisner, M
    Kogut, DG
    Peacock, RA
    Thomson, JM
    Hawkey, CJ
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1998, 12 (02) : 135 - 140
  • [38] Ulcer bleeding and perforation: Non-steroidal anti-inflammatory drugs or Helicobacter pylori
    Svanes, C
    Ovrebo, K
    Soreide, O
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1996, 31 : 128 - 131
  • [39] Gastrointestinal: Ileal ulcers induced by non-steroidal anti-inflammatory drugs
    Matsuura, M.
    Nakase, H.
    Nakamura, F.
    Ueda, Y.
    Mikami, S.
    Yoshino, T.
    Ueno, S.
    Uza, N.
    Chiba, T.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 22 (08) : 1346 - 1346
  • [40] Non-Steroidal Anti-Inflammatory Drug-Induced Enteropathy
    Lim, Yun Jeong
    Yang, Chang-Hun
    CLINICAL ENDOSCOPY, 2012, 45 (02) : 138 - 144